CheckRare: Reducing Barriers to Participate in Clinical Trials
Clincierge CEO Scott Gray recently spoke to CheckRare on the unique challenges of patients in rare disease clinical trials and ways to reduce barriers to participation.
Clincierge CEO Scott Gray recently spoke to CheckRare on the unique challenges of patients in rare disease clinical trials and ways to reduce barriers to participation.
Each February, the rare disease community joins together to celebrate Rare Disease Month. Started in 2008 by the European Organization for Rare Diseases (EURORDIS), the event brings together rare disease patients, caregivers, and advocacy organizations across the globe to advance awareness and increase research opportunities. The Rare Disease Month celebration culminates in Rare Disease Day, …
2023 Rare Disease Day: Getting Involved to Support the Rare Disease Community Read More »
Clincierge CEO Scott Gray recently joined the Empowered Patient Podcast with Karen Jagoda to discuss specialized patient concierge solutions for participants in rare disease clinical trials. He also explained why Clincierge’s 2023 Rare Disease Day sponsorship felt so natural.
Rare Disease Day 2023 is celebrated on Tuesday, February 28, and raises awareness of the over 7,000 identified rare diseases. Our latest blog will help you learn more about what constitutes a “rare” disease and how patient concierge services can improve recruitment and increase retention in your clinical trials.
Clincierge CEO Scott Gray recently joined the Empowered Patient Podcast with Karen Jagoda to discuss specialized patient concierge solutions for participants in rare disease clinical trials. He also explained why Clincierge’s 2023 Rare Disease Day sponsorship felt so natural.
Health IT Issues recently cited Clincierge CEO Scott Gray‘s article Modernizing Clinical Trials in 2023 with Patient Centricity as one of the most-read thought leader posts for December 2022.
Clincierge CEO Scott Gray shares his experiences and best practices for providing patient concierge support services to pediatric clinical trial patients and their caregivers in this new Clinical Research News article.
In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.
Clincierge CEO Scott Gray was recently featured in Citeline’s 2023 Outlook. This annual publication showcases industry thought leaders and forecasts market trends within the clinical trial industry. Amplifying the Patient Voice to Build More Inclusive Clinical Trials His piece in Outlook 2023 entitled Amplifying the Patient Voice to Build More Inclusive Clinical Trials discusses ways …
Outlook 2023: Amplifying the Patient Voice to Build More Inclusive Clinical Trials Read More »
In this Health IT Answers article, Scott Gray, CEO, discusses modern patient-centric methods to remove barriers and increase access in rare disease clinical trials, such as prioritizing patient engagement, embracing digital solutions, and investing in supplemental patient support services.